Clinical Trials Logo

Filter by:
NCT ID: NCT03611504 Completed - Clinical trials for Gastrointestinal Hemorrhage

Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort

Start date: July 1, 2018
Phase:
Study type: Observational

This is an observational, retrospective, analytical, and multicenter study conducted at 17 hospitals. Our research aims to assess the effectiveness of Hemospray® in patients with gastrointestinal bleeding in clinical practice. Besides, we aim to detect predictors of treatment failure defined as unsuccessful immediate hemostasis or rebleeding.

NCT ID: NCT03610776 Completed - Portion Size Clinical Trials

Effect of Tableware Visual Cues on Portion Control and Eating Rate

PORTIONS
Start date: June 19, 2017
Phase: N/A
Study type: Interventional

Randomised within subjects cross-over study (n=94) exploring the cognitive and physiological processes associated with portion control. Participants will eat a self-served lunch using a portion control plate vs. a conventional (control) plate on two separate occasions under a controlled laboratory environment. Portion size, meal micro-structure, attention, memory and satiety markers will be analysed. The portion control plate is a prototype designed in collaboration with the commercial partner for this study and is based on published evidence. It includes sectors and pictures indicating amounts to serve from starchy food, protein and vegetables. The control plate will be of the same background colour, size and shape but without any pictures or demarcations. The main study outcome is attention time on areas of interest in the plate corresponding to main foods groups, across plate conditions.

NCT ID: NCT03610724 Completed - Clinical trials for Non-Hodgkin Lymphoma

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

BIANCA
Start date: February 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the study was to assess the efficacy and safety of tisagenlecleucel in pediatric, adolescent and young adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma (r/r B-NHL) including Burkitt Lymphoma and Burkitt Leukemia. For pediatric patients who have r/r B-NHL including Burkitt Lymphoma and Burkitt Leukemia, survival rates are dismal, only ~20-50% subjects are alive at 2 years with overall response rate (ORR) of 20-30% after conventional salvage chemotherapy.

NCT ID: NCT03610113 Completed - Humeral Fractures Clinical Trials

Reverse Or Nothing For Complex Proximal Humeral Fractures

Start date: September 2016
Phase: N/A
Study type: Interventional

Reverse shoulder prosthesis has recently emerged as an acute treatment for complex proximal humeral fractures. Promising functional results have been reported in observational papers. However, no clinical trials have yet been reported when comparing the conservative treatment to surgical treatment through the use of reverse shoulder arthroplasty.

NCT ID: NCT03609866 Completed - Acute Brain Injury Clinical Trials

Chest Physiotherapy Effects on Intracranial Pressure

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The investigators will study the effects of a chest physiotherapy technique (rapid thoracic compression) on the intracranial pressure of individuals with acute cerebral injury and with need of intubated mechanical ventilation

NCT ID: NCT03608397 Completed - Cervical Dystonia Clinical Trials

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)

ASPEN-1
Start date: June 20, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of two doses of daxibotulinumtoxinA (DAXI) for injection (high-dose; low-dose in adult subjects with isolated (primary) cervical dystonia (CD).

NCT ID: NCT03606512 Completed - Clinical trials for Respiratory Syncytial Virus

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age

Start date: January 21, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and reactogenicity of an intramuscular regimen of 3 doses of 2.5*10^10 viral particles (vp) of adenovirus serotype 26 based respiratory syncytial virus pre-fusion protein (Ad26.RSV.preF) vaccine in RSV-seronegative toddlers aged 12 to 24 months.

NCT ID: NCT03606408 Completed - Cushing's Syndrome Clinical Trials

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Start date: October 5, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is the evaluation of long-term safety of osilodrostat in patients who have already received osilodrostat treatment in a previous Global Novartis-sponsored trial and who, based on investigators' judgement, will continue benefiting with its administration.

NCT ID: NCT03606265 Completed - Chronic Pain Clinical Trials

Utility of a Web-based App for Chronic Pain

Start date: August 15, 2018
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of a web-based app compared to the treatment as usual without an app for the telemonitoring of patients with chronic pain. Two conditions will be set: 1. usual treatment (waiting list) 2. usual treatment + app

NCT ID: NCT03605420 Completed - Depression Clinical Trials

Relatives Visit Prior to Hospital Admission & Intensive Care Unit

Start date: August 22, 2018
Phase: N/A
Study type: Interventional

The present study evaluates the effects of the visit prior to hospital admission on anxiety, depression and satisfaction of family in an intensive care unit.